A clinical trial conducted in the midst of an Ebola epidemic in the Democratic Republic of Congo (DRC) has identified two new drugs that can dramatically cut mortality from the disease, and... Read more
Study in human cells shows it counteracts Ebola’s defenses Amid the worsening Ebola outbreak in the Congo, now threatening to spill into Rwanda, a new study suggests that an existing,... Read more
Two new studies by scientists at Scripps Research are bringing Ebola virus’s weaknesses into the spotlight, showing for the first time exactly how human and mouse antibodies can bind to the... Read more
Sierra Leone’s health ministry yesterday said a new species of Ebola virus has been detected in bats in the north of the country, which would bring the number of known species to six a... Read more
The worst Ebola virus disease outbreak in history ended in 2016 after infecting 28,600 people and killing about 11,300 worldwide. The outbreak led to urgent action by medical experts across... Read more
Ebola Treatment Breakthrough After analyzing the blood of a survivor of the 2013-16 Ebola outbreak, a team of scientists from academia, industry and the government has discovered the first n... Read more
Advance Could Also Work Against Other Viruses In research published online today in Science, a team of scientists describe a new therapeutic strategy to target a hidden Achilles’ heel shared... Read more
A clinical trial of a new Ebola vaccine (ChAd3-EBO-Z) that resulted from an unprecedented global consortium assembled at the behest of the World Health Organization has found that it is well... Read more
Hybrid device integrates a microfluidic chip for sample preparation and an optofluidic chip for optical detection of individual molecules of viral RNA A team led by researchers at UC Santa C... Read more
Potential game changer for treatment and containment A new test can accurately diagnose Ebola virus disease within minutes, providing clinicians with crucial information for treating patient... Read more
An interdisciplinary team from The University of Texas Medical Branch at Galveston and Profectus BioSciences, Inc. has developed a quick-acting vaccine that is both safe and effective with a... Read more
Results from US Government-Sponsored Phase 1 Trial of VSV Vaccine Reported ?An early-stage clinical trial of an experimental Ebola vaccine conducted at the National Institutes of Health (NIH... Read more